The present invention relates to pulse generators and in particular to implantable pulse generators that control pacing functions based on sensed events.
The cardiac pacemaker in its simplest form is an electrical circuit in which a battery provides electricity that travels through a conducting wire through the myocardium, stimulating the heart to beat (“capturing” the heart), and back to the battery, thus completing the circuit. Implantable cardiac pacemakers have been in existence since the later 1950's, although external pacemakers were known even earlier. Since that time great strides have been made in improving upon the leads and the pulse generators that together comprise the pacemaker. In particular, the pulse generator circuitry has evolved from discrete components to semi-custom integrated circuits, which are now fabricated from complimentary metal oxide semi-conductor (CMOS) technology.
As cardiac pacemakers have evolved they have been designed to provide increases in the heart rate for periods when the patient is experiencing physiological stress. These “rate-modulating” pacemakers help the patient adapt to physiological stress with an increase in heart rate, even if the patient's intrinsic heart rate would not allow this to occur. The development of dual-chamber pacemakers has allowed the patient to increase their heart rate if he or she is in sinus rhythm.
The rate-modulated pacemaker has three major components. The first is an indicator, such as for activity, body temperature, or respiratory rate, that provides an approximate measurement of metabolic needs. The second is a sensor that can measure the indicator chosen, such as measurement of body temperature or respiratory rate. The third is a rate controlled algorithm that is in the software of the pacemaker and modulates the pacemaker rate as the sensors send signals to the pacemaker.
As the sensors indicate greater metabolic need, the pacing rate is increased. The rate at which the pacing rate changes, however, is bounded and controlled by a feature called rate smoothing. Rate smoothing is a gradual slowing or speeding of the pacemaker rate based on a percentage of a preceding cardiac interval. This is a mechanism programmed into such types of pacemakers to reduce or to smooth abrupt changes in paced rate, especially at the upper rate limit of dual chamber pacemakers. Conversely, if a patient were to develop an ectopic atrial tachycardia, this programmed feature would cause a gradual increase in rate rather than an abrupt increase in rate.
Rate smoothing may, however, unnecessarily limit a heart rate change under some circumstances. For example, when an individual needs rapid cardiac output in a short time, such as in a stressful situation, rate smoothing may prevent the heart rate from rising rapidly enough to keep up with the individual's cardiac demands. Similarly, once the stressful situation has passed, the individual's pacing rate will decrease under the constraints imposed by the rate smoothing algorithm. Furthermore, the present inventors have also recognized that rate smoothing may interfere with arrhythmia prevention and treatment by limiting a change in heart rate that is needed to prevent or treat the arrhythmia. Thus, there exists an unmet need in the art for more flexible rate smoothing.
The present invention provides a system and method for controlling a rate smoothing system in a pulse generating system. In one embodiment, the rate smoothing system is either activated or deactivated (turned on or turned off) when a triggering event is detected. In an alternative embodiment, when a parameter adjusting events is detected parameters of the rate smoothing system are adjusted (e.g., changed). Under either situation (turning on/off or adjustment of parameters) the changes to the rate smoothing system/function are temporary. In one embodiment, the duration of the changes is over a first time interval, after which the rate smoothing system is either set to the original pre-event state or to a state in which one or more of the original parameter values/settings have been changed from the original pre-event state. By allowing selected events to temporarily activate/deactivate or change parameter settings for a rate smoothing system, greater flexibility in treating a patient's cardiac conditions is achieved as compared to allowing the rate smoothing function to continuously operate. The present subject matter can be used with rate smoothing systems applied to either ventricular pacing or atrial pacing.
In one embodiment, the present system provides monitoring for a trigger signal a parameter adjusting event or both. In one embodiment, the system uses a signal input system, where the signal input system is adapted to detect a signal. Control circuitry coupled to the signal input system receives the signal from the signal input system. In one embodiment, a trigger event detector in the control circuitry receives the signal and analyzes the signal for the occurrence of the trigger event. The trigger event detector is further coupled to a rate smoothing module. In one embodiment, the rate smoothing module executes and controls the rate smoothing algorithm. When the triggering event is detected, the rate smoothing module is then either activated to provide rate smoothing or deactivated to stop rate smoothing, depending upon the state of the module prior to the triggering event. Once the rate smoothing system is activated or deactivated, a timer is used to time a first interval. After the first interval expires, the rate smoothing system is then reset, or restored, to its state prior to the trigger signal. Alternatively, after the first interval expires, the rate smoothing system changes one or more of the original parameter values/settings (i.e., pre-trigger signal parameter state or pre-parameter adjusting event parameter state) to provide a new parameter state. The new parameter state is then used in the rate smoothing system until a subsequent trigger signal and/or parameters adjusting event is detected. A new parameter state can be created after each trigger signal and/or parameters adjusting event (e.g., a sequence of changes to the parameter values and/or settings for the rate smoothing system).
In an alternative embodiment, a parameter adjustment event detector coupled to the control circuitry receives the signal from the signal input system. In one embodiment, the parameter adjustment event detector receives a signal and analyzes the signal for the occurrence of a parameter adjustment event in the signal. When the parameter adjustment event is detected, the rate smoothing module activates and/or adjusts rate smoothing parameters. In one embodiment, the parameters adjusted are a percent limiting a change in pacing rate (for either up or down rate smoothing).
Any number of detected events are used as either triggering events or parameter adjustment events. In one example, a triggering event or a parameter adjustment event is detected in a patient activity signal, such as can be sensed by using an activity monitor, such as an accelerometer or a minute ventilation system. In this example, an activity signal is monitored from an activity sensor. The triggering event or parameter adjustment event is then detected when the patient's activity level exceeds a first predetermined value. In an additional example, the activity signal is a heart rate acceleration, where the triggering event or parameter adjustment event is deemed detected when a change in heart rate exceeds the first predetermined value.
In an additional embodiment, a triggering event or a parameter adjustment event is found in a monitored cardiac signal. In one example, monitoring for the triggering event or parameter adjustment event includes monitoring a cardiac signal, where the cardiac signal includes indications of ventricular contractions. The cardiac signal is analyzed for the occurrence of premature ventricular contractions (PVC). When one or more PVC occur, the triggering event or parameter adjustment event is deemed to have been detected. Alternatively, the a pattern of cycle lengths in the cardiac signal is used as a triggering event or a parameter adjustment event. For example, a detected short-long-short cycle length sequence from a cardiac signal may be used as a triggering event or parameter adjustment event. Alternatively, the triggering event or parameter adjustment event occurs when a cardiac rate exceeds a rate threshold. In an additional embodiment, the triggering event or parameter adjustment event occurs after an arrhythmic episode.
In an alternative embodiment, triggering events or parameter adjustment events occur at selected times within a time interval. In one example, monitoring for the triggering event or parameter adjustment events includes monitoring a time interval, such as the time of the day, week, month, year, or an event, such as a season of the year. The triggering event or parameter adjustment event is then detected at a first time in the time interval, as either programmed by the physician or set based on the implantable system's analysis of one or more detected signals. Alternatively, the triggering event or parameter adjustment event occurs when a pacemaker mode is changed. In one example, an implantable system provides and/or adjusts a rate smoothing system based on whether a state of a monitored signal matches a predetermined state. In one example, the monitored signal is a cardiac signal sensed with electrodes in or about the heart. The cardiac signal matches the predetermined state if a heart rate exceeds a predetermined threshold or, alternatively, falls within a predetermined range of heart rates. In another example, the cardiac rhythm is compared to a predetermined cardiac rhythm state. In yet another example, a patient activity signal (e.g., sensed by an accelerometer or a respiration sensor to represent a patient's metabolic need for a particular range of heart rates) is compared to a predetermined threshold activity level (or range of activity levels). The present inventors have recognized, among other things, that a patient activity level is a useful representation of a physiological state, such as for activating or adjusting rate smoothing.
In one example, a predetermined rate smoothing algorithm is mapped to at least one corresponding predetermined state. The rate smoothing algorithm is selected and applied while the corresponding predetermined state is present. In another example, one or more parameters of a rate smoothing algorithm are mapped to at least one corresponding predetermined state. These rate smoothing parameter(s) are selected and applied while the corresponding predetermined state is present. In one example, such rate smoothing parameters include an up-smoothing percentage to limit a speed of pacing rate increase and a down-smoothing percentage to limit a speed of pacing rate drop. In an alternative example, a rate smoothing algorithm is selected or adjusted based on a physiologic parameter monitored using a sensor. Other aspects of the invention will become apparent upon reading the following detailed description of the invention and viewing the accompanying drawings that form a part thereof.
In the following detailed description, references are made to the accompanying drawings that illustrate specific embodiments in which the invention may be practiced. Electrical, mechanical, programmatic and structural changes may be made to the embodiments without departing from the spirit and scope of the present invention. The following detailed description is, therefore, not to be taken in a limiting sense and the scope of the present invention is defined by the appended claims and their equivalents.
Rate smoothing provides a measure of control over the rate of change of the ventricular pacing rate. Specifically, the rate of change of the ventricular pacing rate is controlled on a cycle-to-cycle basis so as to maintain the rate of change within a programmed percentage of the previous cycle's rate. This function is achieved via the comparison of the ventricular pacing rate for each cycle to a “rate window” or percentage of the period for the previous cardiac cycle so as to ensure that the period of the pacing pulses is constrained from cycle to cycle by the limits defined by the rate window.
Controlling when and under what cardiac conditions to turn on/off or adjust the parameters for a rate smoothing program is highly advantageous. This control allows the rate smoothing to be deactivated when use of rate smoothing would be detrimental, or constraining, to a patient's need for rapid heart rate acceleration or deceleration. Furthermore, by selectively turning rate smoothing off or adjusting rate smoothing parameters, the number of pacing pulses delivered to a patient is reduced.
At 120, the signal is then analyzed to detect the triggering event. When a triggering event is not detected, the signal continues to be analyzed. When a triggering event is detected, the rate smoothing system is activated at 140. Rate smoothing is then applied to control the changes in pacing rate as previously described. The rate smoothing is then deactivated at 160 at a time after activating the rate smoothing. In one embodiment, the time after activating the rate smoothing is a first time interval, where the first time interval is a programmable value. In an additional embodiment, the duration of the first time interval can also be changed based on information contained within either the activity or cardiac signals. Alternatively, the rate smoothing is deactivated based on information in the sensed activity signals or the cardiac signals, where the rate smoothing is deactivated when the one or more triggering events in the signals are no longer detected. Once the rate smoothing is deactivated, the system then returns to 100 to continue to monitor the signal for a triggering event.
At 220, the signal is then analyzed to detect the parameter adjusting event. When a parameter adjusting event is not detected, the signal continues to be analyzed. When a parameter adjusting event is detected, parameters for the rate smoothing system are adjusted at 240. In one embodiment, adjusting the rate smoothing parameters includes making changes to parameter values for either up-smoothing or down-smoothing rate interval changes. For example, changes to the rate interval changes for down-smoothing can be made to set the rate interval in the range of six (6) to twelve (12) percent. Changes to the rate interval for up-smoothing can also be made to change the up-smoothing rate interval from, for example, 25 percent. Rate smoothing is then applied to control the changes in pacing rate as previously described. The parameters of the rate smoothing system are then set to a post-adjusting state at 260. In one embodiment, the post-adjusting state for the parameters and settings of the rate smoothing system includes restoring (i.e., resetting) the parameters and settings to their pre-parameter adjusting event state at a time after adjusting the parameters. Alternatively, adjusting the parameters of the rate smoothing system includes changing one or more of the original parameter values and/or settings (i.e., pre-trigger signal parameter state or pre-parameter adjusting event parameter state) to new parameters values and/or settings in a new parameter state. The new parameter state is then used in the rate smoothing system until a subsequent trigger signal and/or parameters adjusting event is detected. New parameter states can be created after each trigger signal and/or parameters adjusting event (e.g., a sequence of changes to the parameter values and/or settings for the rate smoothing system). This sequence of changes to the parameter values and/or settings also includes a change back to the original setting of the parameter values and/or settings of the rate smoothing system. In one embodiment, the changes to the parameter values and/or settings are based on information from sensed cardiac signals.
In one embodiment, the time after adjusting the parameters is a first time interval, where the first time interval is a programmable value. In an additional embodiment, the duration of the first time interval can also be changed based on information contained within either the activity or cardiac signals. Alternatively, the parameters of the rate smoothing are set to the post-adjusting state based on information in the sensed activity signals or the cardiac signals, where the rate smoothing parameters are set to the post-adjusting state when the one or more parameter adjusting events in the signals are no longer detected. Once the rate smoothing parameters are set to the post-adjusting state, the system then returns to 200 to continue to monitor the signal for a parameter adjusting event.
At 360, either the rate smoothing is deactivated at a time after activating the rate smoothing, or the parameters of the rate smoothing system are set to the post-adjusting state at a time after adjusting the parameters, as previously described, where the time for either deactivating or setting the parameters and/or states of the rate smoothing system at the post-adjusting state are as previously described. Once the rate smoothing has either been deactivated or set to the post-adjusting state, the system then returns to 300 to continue to monitor the signal for the triggering event and/or the parameter adjusting event.
As previously discussed, there exists a variety of triggering and parameter adjusting events. In one embodiment, triggering events or parameter adjustment events are detected in one or more activity signals sensed by using activity monitors. Examples of activity monitors include accelerometers, minute ventilation systems or cardiac rate analyzer. In one embodiment, an activity signal is monitored from at least one of the activity monitors. The activity signal is analyzed to determine whether the activity signal has exceeded a first predetermined value. The triggering event and/or a parameter adjusting event are then detected when the activity signal exceeds the first predetermined value.
Examples of activity signals include a heart rate trajectory (heart rate vs. time) where the event is determined from the slope of the trajectory. Alternatively, the parameter adjusting event and/or the triggering event is detected when the cardiac rate exceeds a rate threshold. In an additional embodiment, the activity signal is an accelerometer signal from an accelerometer. In this embodiment, the amplitude (indication of motion) of the activity signal is analyzed to determine when the first predetermined value has been exceeded. In an alternative embodiment, the activity signal is a minute ventilation signal, where both the amplitude (depth of breath) and the frequency (breathing rate) of the signal are analyzed to determine if either has a value that exceeds the first predetermined value. In one embodiment, the first predetermined value is based on the type of activity sensor being utilized and the portion of the signal that is being analyzed. Programmed values for the first predetermined value will also depend upon the patient's cardiac condition and the type of implantable system that is used to treat the patient. Thus, values for the different applications of the first predetermined value need to be set on a patient-by-patient basis.
In an additional embodiment, triggering events or parameter adjustment events are found in monitored cardiac signals. For example, monitoring for the triggering event or parameter adjustment events includes monitoring a cardiac signal which includes indications of ventricular contractions or atrial contractions. When ventricular contractions are detected, the cardiac signal is analyzed for the occurrence of premature ventricular contractions (PVC). In one embodiment, PVCs are identified based on a comparison of contraction intervals, where PVCs have a shorter interval relative to preceding intervals. In addition, PVCs are also identified based on an analysis of the morphology of the complex wave form (e.g., the QRS-complex wave form), in addition to a contraction interval analysis. When one or more PVC occur, the triggering event or parameter adjustment event is detected.
Alternatively, the cycle length pattern of cardiac cycles detected in the cardiac signal are used as triggering events or parameter adjustment events. For example, a detected short-long-short cycle length sequence from a cardiac signal is a triggering event or parameter adjustment event.
After the second cardiac interval 420, there is a long interval 428. In one embodiment, the long interval 428 is not interrupted by a ventricular pacing pulse as the myocardium are not in the proper state to be captured by the pulse. Ventricular pace 430, however, captures the ventricles, where the ventricular pace 430 is followed by another PVC 434 which results in a second short interval 440. Once this pattern of short-long-short cardiac intervals is presented the triggering event or the parameter adjustment event is detected. The rate smoothing function is then either turned on, or the parameters of the operating rate smoothing system are adjusted.
In an alternative embodiment, triggering events or parameter adjustment events occur at selected times within a time interval. For example, monitoring for the triggering event or parameter adjustment events includes monitoring a time interval, such as the time of the day, week, month, year, or an event, such as a season of the year. The triggering event or parameter adjustment event is then detected at a first time in the time interval, where the first time is either programmed by the physician or set based on the implantable systems analysis of one or more detected signals. For example, when it is known by the physician or determined by the implantable pulse generator that a patient does not experience tachyarrhythmia during a certain time of the day (e.g., in the hours between 12 midnight and 4 a.m.) the triggering event (to turn the rate smoothing off) or the parameter adjustment event can be programmed as occurring at 12 midnight, with the duration of the first time interval lasting for approximately 4 hours.
In an additional embodiment, the triggering event or parameter adjustment event is when a pacemaker mode is changed. For example, when the pacemaker is switched from one mode of operation (e.g., DDD) to a second mode of operation (DVI) a triggering event or parameter adjustment event is detected. Alternatively, the triggering event or parameter adjustment event is when one or more pacing parameters are changed.
Other triggering events or parameter adjustment events include analyzing one or more cardiac signals to detect the occurrence of an arrhythmic episode. In one embodiment, the arrhythmic episodes can include ventricular tachycardias or ventricular bradycardias. Once the arrhythmic episode is treated, an end to the arrhythmic episode is identified. Once the end of the arrhythmic event is identified, the triggering event or parameter adjusting event is declared. The stability of the intervals can also be used as either a triggering event or a parameter adjusting event. In one embodiment, a stability analysis measures the consistency, or variability, of intervals for the sensed contractions. For example, as a cardiac signal is sensed, the consistency of the sensed cardiac intervals are analyzed. When the variability in the cycle length intervals exceeds a set value a stability problem is declared. Once declared, the triggering event or the parameter adjusting event is identified. The user can also request that a triggering event or a parameter adjusting event be considered. In this embodiment, the system receives a request for either a triggering event (e.g., to turn on rate smoothing) or a parameter adjustment event (e.g., make changes to the parameters). The system analyzes the cardiac condition and either issues or denies the request to issue the parameter adjusting event or the triggering event based on the analysis of the cardiac condition.
The system 500 includes control circuitry 520, where the control circuitry 520 is coupled to the signal input system 510. The control circuitry 520 receives the signal from the signal input system 510, where the signal is processed by the control circuitry 520. The control circuitry 520 includes a trigger event detector 530, where the trigger event detector 530 analyzes the signal to detect a trigger event. The control circuitry 520 further includes a parameter adjustment event detector 540, where the parameter adjustment event detector 540 analyzes the signal to detect a parameter adjustment event. The control circuitry 520 further includes a rate smoothing module 550, where the rate smoothing module 550 executes the rate smoothing protocols and makes changes to the rate smoothing parameters once parameter adjustment events are identified. In one embodiment, the components of the control circuitry 520 are under the control of a microcontroller 554. The control circuitry 520 also has communication circuitry which allows the implantable system 500 to communicate with an external programmer 556.
In one embodiment, the cardiac signal sensing system 512 senses and analyzes a ventricular cardiac signal. The ventricular cardiac signal is then analyzed by the trigger event detector 530 and the parameter adjustment event detector 540 to detect any occurrence of a series of consecutive ventricular intervals having a short-long-short sequence as previously discussed. In addition, the trigger event detector 530 and the parameter adjustment event detector 540 also analyze the ventricular cardiac signal to detect premature ventricular contractions in the ventricular cardiac signal as previously discussed.
In an alternative embodiment, the additional input 610 is an accelerometer sensor. Signals from the accelerometer sensor are delivered to both the trigger event detector 530 and the parameter adjustment detector 540. The trigger event detector 530 and the parameter adjustment detector 540 then analyze the signals from the accelerometer sensor to determine when the signal exceeds a first value, as previously discussed.
System 700 further includes an energy output circuit 770, coupled to electrodes 713, to deliver electrical energy pulses to the supraventricular or ventricular regions of heart 714. This delivery of energy pulses to “capture” the heart by triggering resulting heart contractions is referred to as pacing. In one example, cardiac electrodes 713 are coupled to implantable pulse generator housing 715, energy delivery circuit 772, and/or amplifier 712 to allow for unipolar or bipolar pacing of the supraventricular region and/or a ventricular region of heart 714 using electrodes 713. Housing 715 may also function as a reference electrode for unipolar sensing and/or pacing.
System 700 further includes a controller circuit 720, coupled to signal input 710 and energy output 770. Controller 720 receives and analyzes the cardiac signal from amplifier 712. Controller 720 includes an output control module 740, a rate smoothing module 750, and a predetermined state detector 730. Output control module 740 receives inputs from signal input 710 and rate smoothing module 750, determines a pacing rate, and controls energy output 770 to deliver energy pulses to heart 714 at the pacing rate. The pacing rate may be calculated, on a beat-by-beat basis, using a predetermined pacing algorithm. The pacing algorithm defines the timing of the delivery of energy pulses to heart 714 based on the sensed cardiac signal and predetermined parameters such as maximum and minimum pacing rates.
Rate smoothing module 750 may be implemented in hardware, software, and/or firmware to execute at least one rate smoothing algorithm. The rate smoothing algorithm limits a pacing rate based on a preceding heart rate. Output control module 740 includes a rate smoothing system 742 coupled to rate smoothing module 750. In one example, rate smoothing module 750 provides rate smoothing system 742 with rate smoothing parameters including an up-smoothing percentage to limit a speed of pacing rate increase and a down-smoothing percentage to limit a speed of pacing rate drop. The up-smoothing percentage and the down-smoothing percentage may have different or identical values. It may be desirable to use an up-smoothing percentage that is different from a down-smoothing percentage during a particular range of heart rates. For example, when the heart rate is very high, it may be desirable to prevent further increase of heart rate by using a zero up-smoothing percentage while allowing a quick drop of heart rate by using a relatively large down-smoothing percentage. In one example, rate smoothing system 742 multiplies a present heart rate by the up-smoothing percentage. The result is added to the present heart rate to obtain an up-smoothing limit. Rate smoothing system 742 also multiplies the present heart rate by the down-smoothing percentage. The result is subtracted from the present heart rate to obtain a down-smoothing limit. The up-smoothing and down-smoothing limits, updated on a beat-by-beat basis in one example, form a window within which the pacing rate may vary for the next heart beat. If the pacing rate calculated by output control module 740 exceeds the up-smoothing limit or drops below the down-smoothing limit, the pacing rate is instead set to the corresponding one of the up-smoothing limit or the down-smoothing limit.
State detector 730 determines whether a state of the sensed signal matches one or more predetermined states. In the example of
In addition to executing a rate smoothing algorithm, rate smoothing module 750 may select and/or adjust a rate smoothing algorithm. In one operative example, rate smoothing module 750 selects a particular rate smoothing algorithm from the storage medium upon detecting a change in the signal state. In another operative example, rate smoothing module 750 adjusts at least one parameter of a rate smoothing algorithm upon detecting a change in the signal state. Examples of parameters of a rate smoothing system include up-smoothing and down-smoothing percentages, as previously described.
In one example, controller circuit 720 also includes communication circuitry that allows implantable system 700 to communicate with an external programmer 756, which provides a user-interface for implantable system 700. In one example, a physician uses programer 756 to evaluate the cardiac condition of a patient, program implantable system 700 such as to deliver at least one type of therapy, extract a cardiac condition history and/or therapy history stored in implantable system 700, or obtain information about the operative status of implantable system 700.
In the example of
In the example of
It may be desirable to apply different rate smoothing algorithms or alternatively, to apply different parameters for a rate smoothing algorithm, based on a patient's metabolic need for a particular range of heart rates. In one example, the algorithm or parameter selection is used to allow heart rate to increase quickly to meet the metabolic need resulting from exercise. In one example, a first rate smoothing algorithm having a single rate-smoothing percentage parameter is selected when the activity level is below a predetermined activity level (e.g., during a rest). The single rate-smoothing percentage parameter typically has a moderate value and is used for calculating both up-smoothing and down-smoothing limits. When the activity level exceeds the predetermined activity level (e.g., during an exercise), a second rate smoothing algorithm is selected. The second rate smoothing algorithm includes at least a up-smoothing percentage and a different down-smoothing percentage, allowing a quick increase of heart rate by using a relatively large up-smoothing percentage, while inhibiting a quick drop of heart rate by using a zero or a relatively small down-smoothing percentage. In an alternative example, one rate-smoothing algorithm including at least independent up-smoothing and down-smoothing percentage parameters is used at different activity levels. When the activity level is below a predetermined activity level, the up-smoothing and down-smoothing percentages are set to the same value. When the activity level exceeds the predetermined activity level (e.g., during an exercise), the up-smoothing percentage is set to a relatively large value to allow a quick increase of heart rate, while the down-smoothing percentage is set to zero or a relatively small value to inhibit a quick drop of heart rate.
In general, the techniques discussed in this document permit rate smoothing to be activated and/or deactivated, or one or more rate smoothing parameters to be adjusted based on any sensed physiological parameter other than intrinsic electrical cardiac depolarizations, as illustrated generally by
Thus, in
Although specific embodiments have been illustrated and described herein, it will be appreciated by those of ordinary skill in the art that any arrangement which is calculated to achieve the same purpose may be substituted for the specific embodiment shown. This application is intended to cover any adaptations or variations of the present invention. Therefore, it is intended that this invention be limited only by the claims and the equivalents thereof.
This application is a continuation-in-part of U.S. patent application Ser. No. 09/579,951, filed on May 26, 2000, now issued as U.S. Pat. No. 6,501,987, and is related to U.S. patent application Ser. No. 09/570,091, filed May 13, 2000, now abandoned, each of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3857399 | Zacouto | Dec 1974 | A |
4030510 | Bowers | Jun 1977 | A |
4059116 | Adams | Nov 1977 | A |
4163451 | Lesnick et al. | Aug 1979 | A |
4208008 | Smith | Jun 1980 | A |
RE30387 | Denniston, III et al. | Aug 1980 | E |
4432360 | Mumford et al. | Feb 1984 | A |
4503857 | Boute et al. | Mar 1985 | A |
4556063 | Thompson et al. | Dec 1985 | A |
4562841 | Brockway et al. | Jan 1986 | A |
4596255 | Snell et al. | Jun 1986 | A |
4791936 | Snell et al. | Dec 1988 | A |
4809697 | Causey, III et al. | Mar 1989 | A |
4830006 | Haluska et al. | May 1989 | A |
4869252 | Gilli | Sep 1989 | A |
4890617 | Markowitz et al. | Jan 1990 | A |
4905697 | Heggs et al. | Mar 1990 | A |
4917115 | Flammang et al. | Apr 1990 | A |
4920965 | Funke et al. | May 1990 | A |
4928688 | Mower | May 1990 | A |
4940054 | Grevis et al. | Jul 1990 | A |
4941471 | Mehra | Jul 1990 | A |
4944298 | Sholder | Jul 1990 | A |
4944928 | Grill et al. | Jul 1990 | A |
4945909 | Fearnot et al. | Aug 1990 | A |
4972834 | Begemann et al. | Nov 1990 | A |
4998974 | Aker | Mar 1991 | A |
5012814 | Mills et al. | May 1991 | A |
5042480 | Hedin et al. | Aug 1991 | A |
5085215 | Nappholz et al. | Feb 1992 | A |
5101824 | Lekholm | Apr 1992 | A |
5107850 | Olive | Apr 1992 | A |
5127404 | Wyborny et al. | Jul 1992 | A |
5129394 | Mehra | Jul 1992 | A |
5139020 | Koestner et al. | Aug 1992 | A |
5144949 | Olson | Sep 1992 | A |
5156147 | Warren et al. | Oct 1992 | A |
5156154 | Valenta, Jr. et al. | Oct 1992 | A |
5179949 | Chirife | Jan 1993 | A |
5183040 | Nappholz et al. | Feb 1993 | A |
5184614 | Collins et al. | Feb 1993 | A |
5188106 | Nappholz et al. | Feb 1993 | A |
5193535 | Bardy et al. | Mar 1993 | A |
5193550 | Duffin | Mar 1993 | A |
5197467 | Steinhaus et al. | Mar 1993 | A |
5207219 | Adams et al. | May 1993 | A |
5271395 | Wahlstrand et al. | Dec 1993 | A |
5282836 | Kreyenhagen et al. | Feb 1994 | A |
5284491 | Sutton et al. | Feb 1994 | A |
5292339 | Stephens et al. | Mar 1994 | A |
5292341 | Snell | Mar 1994 | A |
5311874 | Baumann et al. | May 1994 | A |
5312452 | Salo | May 1994 | A |
5331966 | Bennett et al. | Jul 1994 | A |
5334220 | Sholder | Aug 1994 | A |
5350409 | Stoop et al. | Sep 1994 | A |
5356425 | Bardy et al. | Oct 1994 | A |
5360437 | Thompson | Nov 1994 | A |
5365932 | Greenhut | Nov 1994 | A |
5372607 | Stone et al. | Dec 1994 | A |
5376106 | Stahmann et al. | Dec 1994 | A |
5379776 | Murphy et al. | Jan 1995 | A |
5383910 | den Dulk | Jan 1995 | A |
5387229 | Poore | Feb 1995 | A |
5391189 | van Krieken et al. | Feb 1995 | A |
5395373 | Ayers | Mar 1995 | A |
5395397 | Lindgren et al. | Mar 1995 | A |
5400796 | Wecke | Mar 1995 | A |
5411524 | Rahul | May 1995 | A |
5411531 | Hill et al. | May 1995 | A |
5417714 | Levine et al. | May 1995 | A |
5423869 | Poore et al. | Jun 1995 | A |
5431691 | Snell et al. | Jul 1995 | A |
5437285 | Verrier et al. | Aug 1995 | A |
5462060 | Jacobson et al. | Oct 1995 | A |
5474574 | Payne et al. | Dec 1995 | A |
5480413 | Greenhut et al. | Jan 1996 | A |
5486198 | Ayers et al. | Jan 1996 | A |
5487752 | Salo et al. | Jan 1996 | A |
5507782 | Kieval et al. | Apr 1996 | A |
5507784 | Hill et al. | Apr 1996 | A |
5514163 | Markowitz et al. | May 1996 | A |
5522850 | Yomtov et al. | Jun 1996 | A |
5522859 | Stroebel et al. | Jun 1996 | A |
5523942 | Tyler et al. | Jun 1996 | A |
5527347 | Shelton et al. | Jun 1996 | A |
5534016 | Boute | Jul 1996 | A |
5540232 | Laney et al. | Jul 1996 | A |
5540727 | Tockman et al. | Jul 1996 | A |
5545182 | Stotts et al. | Aug 1996 | A |
5545186 | Olson et al. | Aug 1996 | A |
5549649 | Florio et al. | Aug 1996 | A |
5549654 | Powell | Aug 1996 | A |
5554174 | Causey, III | Sep 1996 | A |
5560369 | McClure et al. | Oct 1996 | A |
5560370 | Verrier et al. | Oct 1996 | A |
5562711 | Yerich et al. | Oct 1996 | A |
5584864 | White | Dec 1996 | A |
5584867 | Limousin et al. | Dec 1996 | A |
5591215 | Greenhut et al. | Jan 1997 | A |
5605159 | Smith et al. | Feb 1997 | A |
5607460 | Kroll et al. | Mar 1997 | A |
5613495 | Mills et al. | Mar 1997 | A |
5620471 | Duncan | Apr 1997 | A |
5620473 | Poore | Apr 1997 | A |
5622178 | Gilham | Apr 1997 | A |
5626620 | Kieval et al. | May 1997 | A |
5626622 | Cooper | May 1997 | A |
5626623 | Kieval et al. | May 1997 | A |
5632267 | Hognelid et al. | May 1997 | A |
5674250 | de Coriolis et al. | Oct 1997 | A |
5674251 | Combs et al. | Oct 1997 | A |
5674255 | Walmsley et al. | Oct 1997 | A |
5676153 | Smith et al. | Oct 1997 | A |
5683429 | Mehra | Nov 1997 | A |
5690689 | Sholder | Nov 1997 | A |
5700283 | Salo | Dec 1997 | A |
5702424 | Legay et al. | Dec 1997 | A |
5713929 | Hess et al. | Feb 1998 | A |
5713930 | van der Veen et al. | Feb 1998 | A |
5713932 | Gillberg et al. | Feb 1998 | A |
5716382 | Snell | Feb 1998 | A |
5716383 | Kieval et al. | Feb 1998 | A |
5716384 | Snell | Feb 1998 | A |
5718235 | Golosarsky et al. | Feb 1998 | A |
5724985 | Snell et al. | Mar 1998 | A |
5725559 | Alt et al. | Mar 1998 | A |
5725561 | Stroebel et al. | Mar 1998 | A |
5730141 | Fain et al. | Mar 1998 | A |
5730142 | Sun et al. | Mar 1998 | A |
5738096 | Ben-Haim | Apr 1998 | A |
5741304 | Patwardhan et al. | Apr 1998 | A |
5741308 | Sholder | Apr 1998 | A |
5749901 | Bush et al. | May 1998 | A |
5749906 | Kieval et al. | May 1998 | A |
5755736 | Gillberg et al. | May 1998 | A |
5755737 | Prieve et al. | May 1998 | A |
5755739 | Sun et al. | May 1998 | A |
5755740 | Nappholz | May 1998 | A |
5759196 | Hess et al. | Jun 1998 | A |
5776164 | Ripart | Jul 1998 | A |
5776167 | Levine et al. | Jul 1998 | A |
5782887 | Van Krieken et al. | Jul 1998 | A |
5788717 | Mann et al. | Aug 1998 | A |
5792193 | Stoop | Aug 1998 | A |
5800464 | Kieval | Sep 1998 | A |
5800471 | Baumann | Sep 1998 | A |
5814077 | Sholder et al. | Sep 1998 | A |
5814081 | Ayers et al. | Sep 1998 | A |
5814085 | Hill | Sep 1998 | A |
5836975 | DeGroot | Nov 1998 | A |
5836987 | Baumann et al. | Nov 1998 | A |
5840079 | Warman et al. | Nov 1998 | A |
5842997 | Verrier et al. | Dec 1998 | A |
5846263 | Peterson et al. | Dec 1998 | A |
5853426 | Shieh | Dec 1998 | A |
5855593 | Olson et al. | Jan 1999 | A |
5861007 | Hess et al. | Jan 1999 | A |
5865838 | Obel et al. | Feb 1999 | A |
5873895 | Sholder et al. | Feb 1999 | A |
5873897 | Armstrong et al. | Feb 1999 | A |
5891178 | Mann et al. | Apr 1999 | A |
5893882 | Peterson et al. | Apr 1999 | A |
5897575 | Wickham | Apr 1999 | A |
5902324 | Thompson et al. | May 1999 | A |
5928271 | Hess et al. | Jul 1999 | A |
5931857 | Prieve et al. | Aug 1999 | A |
5935081 | Kadhiresan | Aug 1999 | A |
5944744 | Paul et al. | Aug 1999 | A |
5951592 | Murphy | Sep 1999 | A |
5968079 | Warman et al. | Oct 1999 | A |
5974341 | Er et al. | Oct 1999 | A |
5978707 | Krig et al. | Nov 1999 | A |
5978710 | Prutchi et al. | Nov 1999 | A |
5983138 | Kramer | Nov 1999 | A |
5987354 | Cooper et al. | Nov 1999 | A |
5987356 | DeGroot | Nov 1999 | A |
5991656 | Olson et al. | Nov 1999 | A |
5991657 | Kim | Nov 1999 | A |
5991662 | Kim et al. | Nov 1999 | A |
5999850 | Dawson et al. | Dec 1999 | A |
6026320 | Carlson et al. | Feb 2000 | A |
6041251 | Kim et al. | Mar 2000 | A |
6044298 | Salo et al. | Mar 2000 | A |
6047210 | Kim et al. | Apr 2000 | A |
6049735 | Hartley et al. | Apr 2000 | A |
6052617 | Kim | Apr 2000 | A |
6052620 | Gillberg et al. | Apr 2000 | A |
6058328 | Levine et al. | May 2000 | A |
6081745 | Mehra | Jun 2000 | A |
6081746 | Pendekanti et al. | Jun 2000 | A |
6081747 | Levine et al. | Jun 2000 | A |
6081748 | Struble et al. | Jun 2000 | A |
RE36765 | Mehra | Jul 2000 | E |
6085116 | Pendekanti et al. | Jul 2000 | A |
6088618 | Kerver | Jul 2000 | A |
6091988 | Warman et al. | Jul 2000 | A |
6096064 | Routh | Aug 2000 | A |
6122545 | Struble et al. | Sep 2000 | A |
6128529 | Esler | Oct 2000 | A |
6129745 | Sun et al. | Oct 2000 | A |
6134469 | Wietholt | Oct 2000 | A |
6151524 | Krig et al. | Nov 2000 | A |
6223072 | Mika et al. | Apr 2001 | B1 |
6246909 | Ekwall | Jun 2001 | B1 |
6256534 | Dahl | Jul 2001 | B1 |
6263242 | Mika et al. | Jul 2001 | B1 |
6266554 | Hsu et al. | Jul 2001 | B1 |
6272380 | Warman et al. | Aug 2001 | B1 |
6285907 | Kramer et al. | Sep 2001 | B1 |
6292693 | Darvish et al. | Sep 2001 | B1 |
6317632 | Krig et al. | Nov 2001 | B1 |
6351669 | Hartley et al. | Feb 2002 | B1 |
6353759 | Hartley et al. | Mar 2002 | B1 |
6353761 | Conley et al. | Mar 2002 | B1 |
6408209 | Bouhour et al. | Jun 2002 | B1 |
6411847 | Mower | Jun 2002 | B1 |
6411848 | Kramer et al. | Jun 2002 | B2 |
6424865 | Ding | Jul 2002 | B1 |
6430438 | Chen et al. | Aug 2002 | B1 |
6434424 | Igel et al. | Aug 2002 | B1 |
6438410 | Hsu et al. | Aug 2002 | B2 |
6501987 | Lovett et al. | Dec 2002 | B1 |
6501988 | Kramer et al. | Dec 2002 | B2 |
6512951 | Marcovecchio et al. | Jan 2003 | B1 |
6522925 | Gilkerson et al. | Feb 2003 | B1 |
RE38119 | Mower | May 2003 | E |
6687541 | Marcovecchio et al. | Feb 2004 | B2 |
6847842 | Rodenhiser et al. | Jan 2005 | B1 |
6957100 | Vanderlinde et al. | Oct 2005 | B2 |
6988002 | Kramer et al. | Jan 2006 | B2 |
7142915 | Kramer et al. | Nov 2006 | B2 |
20020062139 | Ding | May 2002 | A1 |
20020082509 | Vanderlinde et al. | Jun 2002 | A1 |
20020082660 | Stahmann et al. | Jun 2002 | A1 |
20020087198 | Kramer et al. | Jul 2002 | A1 |
20020120298 | Kramer et al. | Aug 2002 | A1 |
20030004551 | Chen et al. | Jan 2003 | A1 |
20030069610 | Kramer et al. | Apr 2003 | A1 |
20030078630 | Lovett et al. | Apr 2003 | A1 |
20030233131 | Kamer et al. | Dec 2003 | A1 |
20040010295 | Kramer et al. | Jan 2004 | A1 |
20040172076 | Stahmann et al. | Sep 2004 | A1 |
20040215259 | Krig et al. | Oct 2004 | A1 |
Number | Date | Country |
---|---|---|
0033418 | Dec 1980 | EP |
0360412 | Mar 1990 | EP |
0401962 | Dec 1990 | EP |
0597459 | May 1994 | EP |
0617980 | Oct 1994 | EP |
0748638 | Dec 1996 | EP |
WO-9302746 | Feb 1993 | WO |
WO-9509029 | Apr 1995 | WO |
WO-9711745 | Apr 1997 | WO |
WO-9739798 | Oct 1997 | WO |
WO-9848891 | Nov 1998 | WO |
WO-0071200 | Nov 2000 | WO |
WO-0071202 | Nov 2000 | WO |
WO-0071203 | Nov 2000 | WO |
Number | Date | Country | |
---|---|---|---|
20020091415 A1 | Jul 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09579951 | May 2000 | US |
Child | 10017800 | US |